Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „antagonists“
Suchtreffer
Begriffe & Kennungen
Amgevita · 4.8 · Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as AMGEVITA affect the immu
Eintrag öffnenAmsparity · 4.8 · Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as adalimumab affect the im
Eintrag öffnenAmsparity · 4.8 · Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as adalimumab affect the im
Eintrag öffnenAmsparity · 4.8 · Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as adalimumab affect the im
Eintrag öffnenAnalgetika, Opioid-
Eintrag öffnenAndrogenantagonisten
Eintrag öffnenAndrogenrezeptor-Antagonisten
Eintrag öffnenAngiogenese-Inhibitoren
Eintrag öffnenAngiotensin-Converting-Enzym-Hemmer
Eintrag öffnenAngiotensin-II-Typ-1-Rezeptorenblocker
Eintrag öffnenAngiotensin-II-Typ-2-Rezeptorblocker
Eintrag öffnenAngiotensin-Rezeptor-Antagonisten
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Co-administration of umeclidinium/vilanterol with other long-acting muscarinic antagonists, long-acting beta2-
Eintrag öffnenAntithyreodika
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnen